By Shari Roan, Los Angeles Times Staff Writer
New Delhi, Delhi, India, Friday, June 20, 2008 -- (Business Wire India)
The studies and survey conducted by Australian Health Research Institute indicates that due to billions of times more in volume electromagnetic radiation emitted by billions of mobile phones, internet, intranet and wireless communication data transmission will make almost 1/3 rd of world population (about 2 billions) patient of ear, eye and brain cancer beside other major body disorders like heart ailments, impotency, migraine, epilepsy etc. According to the reports the tissues of children are tender and are likely to be more effected by use of any wireless gadget and devices and they should not be encouraged to use mobile phone. The fatal and volumetric effects of Electromagnetic Radiation emitted mainly by mobile phones, Mobile phone antenna, tower, Mast, Transmission Tower, Microwave oven, wireless devices, system and equipment. These dangerous effects have been certified and confirmed repeatedly by many leading medical and scientific research institutions of the world including Ministries of health of various governments, W.H.O. and now have been admitted and confirmed by Govt. of India in their recent press releases.
The attached image shows and proves about the serious ill effects of E.M. radiation released by Radiation Nuclear and Safety Authority of FINLAND as to how E.M. radiation emitted by mobile phones damages the various body cells and causes incurable and fatal diseases.
By JOSEPH DOUGHERTY
June 13, 2008
Every morning I begin craving my cocktail — a drug cocktail. My life likely depends on it. I suspect Senator Kennedy will develop a similar appreciation for "drug cocktails" since his recent diagnosis with the same form of incurable brain cancer.
| Friday, 13 June , 2008, 12:32 | |||
| |||
"U.S. Senator Edward Kennedy." Kennedy remained awake and alert during the entire procedure, doctors said. By keeping him awake, they were able to map the brain's key areas, like those that control movement and speech, and avoid cutting into them. His doctors were also able to use "neuronavigation techniques" to map his brain's cancerous areas. Doing this helped surgeons to better target the cancer and get all of it out. Medical researchers have learned a lot about the brain in recent years, especially about the relationships between the brain's structure and functions. Understanding the brain has revolutionized diagnosis, treatment, and further research of a variety of conditions, including brain cancer and Alzheimer's disease. In this lesson, your own investigations will discover how exactly the brain works within the larger network of the nervous system. DallasNews.com
Wednesday, June 11, 2008
On Monday, June 2, 2008, surgeons at Duke University Medical Center announced that they had successfully removed a cancerous tumor from Sen. Edward Kennedy's brain. 
Priyanka Golikeri/ DNA MONEY
Tuesday, 10 June , 2008, 08:44 Cancer, which is caused by faulty genes, kills about 7.5 million people globally each year, according to the World Health Organisation (WHO).
But the good news is, drugs which rectify the faulty genes —- and which can be used to treat breast, skin, prostate, and brain cancers —- would be introduced in India by 2014-15. About 80-90% of all cancers are caused by faulty genes or deficiency of a particular type of gene, says oncologist V Nair from Apollo Hospital, New Delhi. "Gene therapy is a multi-pronged approach which might help to a large extent in controlling the disease. 80% of breast and ovarian cancers are due to faulty genes," says gynaecologist Ranu Patni of Fortis Escorts Hospitals, Jaipur. Gene therapy works like this:
The lack of a gene called MSP36 is believed to cause breast and prostrate cancer. To correct this, a virus is genetically engineered with the MSP36 gene and introduced in the body of the patient through a drug. The gene produces a protein, also called MSP36, which stops blood vessels around the cell from being formed. "This cuts nutrition supply to the cells, which then can't multiply and die out," explains Sanjeev Saxena, chairman and CEO of Actis Biologics Pvt Ltd, the biotechnology company that is currently conducting the lab tests for such drugs. For skin and brain cancers, the virus is infused with a gene called IL21, and introduced in the patient's body. This stops random multiplication of the cancer cells, and simultaneously increase the immunity of the cells to produce proteins such as MSP36 that can kill the cancer cells, says Saxena.
"Lab tests are proving our assumptions and we hope the same would happen with the clinical trials also." It would take six to seven years for the drugs to hit the Indian market, after going through animal and human trials, according to experts.
Thank you for allowing me to listen to you regarding your support for Brain Tumor Awareness Month. I appreciate you taking time to share your views with me.
Brain tumors can affect any part of the brain and claim nearly 13,000 lives a year. It is estimated that over 43,000 new cases of brain tumors are discovered every year. In spite of recent research, brain tumors are often inoperable and untreatable.
As a physician, I fully understand the suffering and hardship that brain tumors can wreak on individuals and families, and I am committed to working to lessen the impact of this disease. You may be pleased to know that the House of Representatives unanimously passed H. Res. 1124, which would establish a National Brain Tumor Awareness Month last month.
As you may be aware, Senator Ted Kennedy was recently diagnosed with a malignant brain tumor. This has drawn media attention to the risks associated with brain tumors, and the ways in which they can be treated. Congress would do well to heed this opportunity to push for new research with the promise of new treatments.
Thank you again for sharing your concerns with me. By working together, we will build a better future for everyone.
| J Neurol. 2008 May 30; [Epub ahead of print] | Related Articles |
Tang V, Rathbone M, Park Dorsay J, Jiang S, Harvey D. Division of Neurology, McMaster University, Hamilton, Canada. OBJECTIVE : Patients with brain tumours have major disabilities and guarded prognosis but may benefit from inpatient rehabilitation. The objectives were to compare functional outcomes in patients with glioblastoma multiforme (GBM), brain metastases and other brain tumours, and to determine predictors of survival. METHODS : Demographic, clinical, functional, and survival data were collected for 63 patients.Kaplan-Meier and Cox regression were used for survival analyses. RESULTS : Functional Independence Measure (FIMtrade mark) scores improved from admission to discharge for patients with GBM, brain metastases and other tumours. Estimated median survival was 141 days for brain metastases, 214 days for GBM and 439 days for other tumours. Low admission dexamethasone dose and high FIMtrade mark gain predicted better survival in GBM. For brain metastases, high FIMtrade mark gain, low dexamethasone dose and no organ metastases were positive prognostic factors. CONCLUSIONS : Patients with primary and metastatic brain tumours achieved functional gains after rehabilitation. High functional improvement is a significant predictor of longer survival in brain metastases and GBM. This study has implications for rehabilitation in the post-acute management of patients who have disabilities due to brain tumours. PMID: 18500499 [PubMed - as supplied by publisher] |
The brain is a highly specialized organ. Different sections control very specific functions. The location of tumors in the brain is one of the factors that determines how a brain tumor affects an individual's functioning and what symptoms the tumor causes.
By ESTES THOMPSON – 5 hours ago
RALEIGH, N.C. (AP) — Dr. John Sampson has spent most of his career studying brain tumors. And if diagnosed with the kind of cancer now faced by Sen. Edward Kennedy, he'd pick Duke University colleague Allan Friedman for a doctor.
"He's one of the best for this type of surgery in the world," Sampson said. "If someone had to choose, he would certainly be on the top of my list."
For the delicate task of removing the cancerous brain tumor that threatens his life, Kennedy went with Friedman, a 59-year-old Chicago native is a respected leader in the field of neuro-oncology who performs the majority of such surgeries at Duke University Medical Center.
Friedman "is one of the thought leaders" in the field of neuro-oncology, said Dr. Otis Brawley, the top doctor at the American Cancer Society. An internationally known tumor and vascular surgeon, he is responsible for more than 90 percent of tumor resections and biopsies at Duke.
